Sandeep Kumar Soni

Sandeep Kumar Soni Here you will pharma marketing,Sales growth steps and marketing updates and business case studies

How ASMs should handle underperforming HQs in MayEvery pharma company has some territories (HQs) that underperform.May i...
17/05/2026

How ASMs should handle underperforming HQs in May

Every pharma company has some territories (HQs) that underperform.

May is the right time to identify and correct these areas.

But handling underperforming HQs requires a balanced approach.

Not all underperformance is due to lack of effort.

Here’s how ASMs should approach this.

⭐ Diagnose the real problem
Is it low doctor potential, weak MR, or strong competition?

⭐ Review doctor coverage
Are high-potential doctors being targeted properly?

⭐ Check MR capability
Some MRs may need training, not pressure.

⭐ Evaluate distributor support
Poor distribution can limit growth.

⭐ Analyze brand fit
Some brands may not suit certain territories.

Once the root cause is clear, corrective steps can be taken.

⭐ Increase joint working frequency
Direct observation improves understanding.

⭐ Provide focused coaching
Help MR improve specific skills.

⭐ Adjust targets if needed
Unrealistic targets demotivate.

⭐ Re-align doctor strategy
Focus on achievable opportunities.

⭐ Consider territory restructuring
In some cases, HQ adjustment may be required.

Another important factor is communication style.

ASMs should avoid blame.

Instead, they should create a problem-solving environment.

When MRs feel supported, they are more willing to improve.

Startups must remember:

One weak territory can affect overall performance.

But overreacting can damage team morale.

Balanced leadership is the key.

👉 How do you usually handle underperforming territories — pressure or support?

When NOT to increase pressure on field forceIn pharma sales, pressure is often seen as a tool to drive performance.But o...
16/05/2026

When NOT to increase pressure on field force

In pharma sales, pressure is often seen as a tool to drive performance.

But one important leadership skill is knowing when NOT to increase pressure.

Because the wrong pressure at the wrong time can reduce productivity instead of improving it.

Here are situations where increasing pressure can backfire.

⭐ When strategy is unclear
If MRs are not sure what to do, pressure only creates confusion.

⭐ When brand communication is weak
Without strong messaging, more visits won’t improve results.

⭐ When doctor response is still developing
Prescription change takes time.

⭐ When MR confidence is low
Pressure reduces confidence further.

⭐ When market conditions are challenging
External factors sometimes slow growth.

In these situations, the focus should shift from pressure to support and correction.

⭐ Improve training
⭐ Clarify brand positioning
⭐ Guide doctor targeting
⭐ Strengthen follow-up approach

Another common mistake is comparing territories unfairly.

Each area has different potential and competition level.

Uniform pressure creates frustration.

Smart managers observe first, then decide.

They ask:

⭐ Is the issue effort or direction?
⭐ Is the MR working but struggling?
⭐ Is the market ready for growth?

If effort is high but output is low, solution is not pressure — it is guidance.

Remember:

Pressure increases activity.
Clarity improves results.

Startups should build a culture of smart ex*****on, not blind pressure.

Because long-term performance comes from capability, not fear.

👉 Do you think pressure improves performance — or reduces it?

16/05/2026

Are you expecting prescriptions after just one doctor visit? That is one of the biggest mistakes in pharma marketing.

In this video, learn the Frequency Dominance Model (FVM) — a practical strategy for Medical Representatives to improve doctor recall and prescription generation.

F.V.M Framework:
• F = Frequency – Meet doctors consistently
• V = Visibility – Stay regularly seen
• M = Memory – Build strong brand recall

Who is this for?

Pharma Founders & Entrepreneurs

Sales & Marketing Managers

Ambitious Medical Representatives

Action Task for Today:
Watch the video and identify which step of the framework your team is missing. Comment "DAY 9" if you're committed to the 30-day journey!

Mid-Q1 correction plan – practical stepsBy mid-May, enough data is available to make corrections.This is the best time t...
15/05/2026

Mid-Q1 correction plan – practical steps

By mid-May, enough data is available to make corrections.

This is the best time to adjust strategy before problems grow.

Here’s a practical correction approach.

⭐ Re-evaluate brand focus
Identify top-performing and weak brands.

⭐ Strengthen doctor targeting
Focus on high-potential doctors.

⭐ Improve MR communication
Fix message clarity issues.

⭐ Adjust territory priorities
Support weaker areas.

⭐ Control stock and billing
Avoid unnecessary inventory buildup.

Another important step is team alignment.

Everyone should clearly understand:

⭐ What is changing
⭐ Why it is changing
⭐ What is expected next

Without alignment, correction fails.

Also, avoid over-correction.

Too many changes create confusion.

Focus on 2–3 key improvements.

Startups have an advantage here.

They can adapt quickly.

Large companies take time to change direction.

But correction must be timely.

Delaying action increases pressure later.

Remember:

Early correction = controlled growth
Late correction = stressful recovery

👉 Do you actively correct strategy in May — or wait till later?

Why most companies panic in MayMay is the month where reality starts becoming visible.And for many companies, this creat...
14/05/2026

Why most companies panic in May

May is the month where reality starts becoming visible.

And for many companies, this creates panic.

Why?

Because expectations from April don’t always match actual results.

Here are common reasons for panic.

⭐ Slow prescription growth
Early traction may not meet expectations.

⭐ Distributor pressure
Stock movement may be slower than planned.

⭐ Target anxiety
Management starts worrying about yearly goals.

⭐ Field performance gaps
Ex*****on issues become visible.

⭐ Comparison with competitors
Others may appear to be doing better.

But panic is not a solution.

It often leads to wrong decisions.

⭐ Sudden target increase
⭐ Unplanned schemes
⭐ Frequent strategy changes
⭐ Excessive pressure on field

These actions create confusion.

Instead of panic, companies need calm analysis.

⭐ Understand root cause
⭐ Identify correctable gaps
⭐ Focus on key priorities
⭐ Maintain consistency

Pharma growth takes time.

It is not instant.

Companies that stay stable in May usually perform better in long term.

Because they correct intelligently instead of reacting emotionally.

Sunday reminder:

Panic reduces clarity.
Clarity improves decisions.

👉 Do companies panic too early — or is pressure justified?

Doctor objections you will hear more in MayBy May, doctors have already heard your brand introduction.Now their question...
13/05/2026

Doctor objections you will hear more in May

By May, doctors have already heard your brand introduction.

Now their questions become sharper.

This is a critical stage.

Because how MRs handle objections now decides future conversion.

Common objections in May include:

⭐ “I already use another brand”
Doctors prefer established options.

⭐ “I need to see results first”
They are waiting for proof.

⭐ “Price is high”
Cost sensitivity may come into discussion.

⭐ “Company is new”
Trust is still building.

⭐ “No patient demand yet”
Doctors may not see strong reason to switch.

These objections are normal.

They indicate that the doctor is evaluating the brand seriously.

MRs should be trained to handle these calmly.

Here’s the right approach.

⭐ Listen fully before responding
Interrupting reduces impact.

⭐ Acknowledge concern respectfully
Shows professionalism.

⭐ Give simple, clear answer
Avoid complicated explanations.

⭐ Share logical benefit
Focus on practical advantage.

⭐ Encourage small trial
Trial reduces hesitation.

Another key factor is confidence.

If MR is unsure, doctor also feels unsure.

That’s why training and preparation are important.

Managers should collect common objections and create standard response guidelines.

This improves consistency across team.

Remember:

Objections are not rejection.

They are opportunity to build trust.

👉 Which objection do your MRs struggle with the most?

13/05/2026

Stop Saying the Same Thing and Becoming Invisible to Doctors | USP Model for Medical Reps

Are you using the same generic pitch in every doctor call? Then chances are you are becoming invisible.

A doctor listens to multiple MRs every day. If your communication sounds like everyone else, your message gets ignored. In this video, I explain a powerful USP Model for Medical Representatives that helps you stand out and create better impact during prescription generation.

In This Video You’ll Learn:

Why generic detailing fails
Doctors hear similar product pitches from many reps daily.

U.S.P Model Explained

U = Unique Angle
Present your brand with a different and meaningful perspective.

S = Specific Case
Use targeted patient scenarios instead of broad claims.

P = Positioning
Place your brand clearly in the doctor’s mind.

Field Demo Example:

“Sir, specially recurrent patients me better result.”

This type of pitch creates relevance and improves recall.

Action Step:

Stop using generic pitch. Start using framework-based sales strategy.

If you are a Medical Representative, Area Manager, Pharma Sales Trainer, or PCD professional, this video will help improve your doctor conversion skills.

For more in depth information book consultation call with Sandeep Kumar Soni and Talk with him
Visit www.sandeepkumarsoni.com/service

How to correct MR ex*****on without demotivationCorrecting field ex*****on is necessary.But doing it wrong can demotivat...
12/05/2026

How to correct MR ex*****on without demotivation

Correcting field ex*****on is necessary.

But doing it wrong can demotivate the team.

Many managers make this mistake:

They focus only on what is wrong.

This creates fear, not improvement.

The goal should be:

👉 Correction with confidence.

Here’s how to do it.

⭐ Focus on behaviour, not personality
Correct the action, not the person.

⭐ Use real examples
Show where improvement is needed through field observation.

⭐ Appreciate effort first
Recognition builds openness to feedback.

⭐ Give clear improvement steps
Vague feedback does not help.

⭐ Follow up consistently
Improvement requires repetition.

Another important point is tone of communication.

If feedback feels like criticism, MRs resist.

If it feels like support, they improve.

Managers should act like coaches, not inspectors.

⭐ Guide during joint working
⭐ Demonstrate better communication
⭐ Help in difficult situations

Also, set realistic expectations.

Not every MR improves instantly.

But consistent guidance builds capability over time.

Startups should remember:

Motivated teams learn faster.

Demotivated teams avoid responsibility.

Correction should increase confidence — not reduce it.

Because in pharma sales, people performance drives business performance.

👉 What motivates MRs more — pressure or support?

MR activity vs output gap analysisOne of the most common issues in pharma companies is this:👉 MRs are working… but resul...
11/05/2026

MR activity vs output gap analysis

One of the most common issues in pharma companies is this:

👉 MRs are working… but results are not coming.

This creates confusion for both management and field teams.

Because activity is visible — but output is not.

This gap between effort and result needs to be analyzed carefully.

Here’s how to understand the problem.

⭐ High calls, low conversion
MRs are visiting many doctors but prescriptions are not increasing.

⭐ Repetition without impact
Same doctors are visited but communication is not improving.

⭐ Weak brand positioning
Doctors do not clearly understand the product benefit.

⭐ Poor follow-up quality
Follow-up is happening, but not with purpose.

⭐ Wrong doctor selection
Effort is spent on low-potential doctors.

Many companies react incorrectly by increasing pressure.

But pressure does not fix the gap.

Correction does.

Here’s what should be done.

⭐ Observe actual doctor calls
Joint working reveals real communication gaps.

⭐ Improve message clarity
Focus on one strong benefit.

⭐ Re-align doctor targeting
Prioritize high-potential doctors.

⭐ Train on objection handling
Confidence improves conversion.

⭐ Monitor quality, not just quantity
Better calls matter more than more calls.

Another important insight:

Activity is under MR control.
Output depends on skill + strategy + consistency.

So if output is low, focus should be on improving ex*****on quality.

Startups must build a culture where:

⭐ Learning is encouraged
⭐ Feedback is accepted
⭐ Improvement is continuous

Because pharma growth is not just about working hard.

It is about working right.

👉 Do you think most companies measure activity more than output?

11/05/2026

Hello Friends

Doctors don’t prescribe what they don’t remember.
Simple truth: memory is built through repetition.

In this video, you’ll learn:

Framework: 3R SYSTEM
● R = Repeat
● R = Reinforce
● R = Recall

Action Task for Today:
Watch the video and identify which step of the framework your team is missing. Comment "DAY 7" if you're committed to the 30-day journey!

Scheme response review – working or damaging?By May, companies can evaluate how their schemes are performing.This is imp...
10/05/2026

Scheme response review – working or damaging?

By May, companies can evaluate how their schemes are performing.

This is important because schemes can either boost growth or damage brand value.

Let’s analyze properly.

Signs that schemes are working:

⭐ Increased secondary movement
⭐ Faster stock rotation
⭐ Better retailer interest
⭐ Improved distributor confidence

But there are warning signs too.

⭐ Sales drop when scheme stops
⭐ Doctors not aware of brand
⭐ Distributor only ordering during offers
⭐ Margin pressure increasing

These signals indicate dependency.

Scheme dependency is dangerous.

Because it shifts focus from prescription → discount.

Correct approach in May:

⭐ Evaluate real demand vs scheme-driven demand
⭐ Reduce unnecessary discounts
⭐ Strengthen doctor promotion
⭐ Use schemes strategically, not regularly

Schemes should support growth — not replace effort.

Another important point:

Short-term boost should not damage long-term brand positioning.

If brand survives only on offers, it is weak.

If brand grows with doctor support, it is strong.

👉 Are your schemes building demand — or hiding weak promotion?

Address

Hanumanganj Road
Allahabad
221507

Website

Alerts

Be the first to know and let us send you an email when Sandeep Kumar Soni posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category